SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-124392
Filing Date
2020-11-12
Accepted
2020-11-12 16:05:32
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029594-1_10q.htm 10-Q 480960
2 EXHIBIT 31.1 tm2029594d1_ex31-1.htm EX-31.1 10506
3 EXHIBIT 31.2 tm2029594d1_ex31-2.htm EX-31.2 12036
4 EXHIBIT 32.1 tm2029594d1_ex32-1.htm EX-32.1 3627
5 EXHIBIT 32.2 tm2029594d1_ex32-2.htm EX-32.2 3402
  Complete submission text file 0001104659-20-124392.txt   4622508

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyen-20200930.xml EX-101.INS 1226124
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20200930.xsd EX-101.SCH 48441
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyen-20200930_cal.xml EX-101.CAL 41424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyen-20200930_def.xml EX-101.DEF 130541
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20200930_lab.xml EX-101.LAB 326171
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20200930_pre.xml EX-101.PRE 271896
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 201306590
SIC: 2834 Pharmaceutical Preparations